ZBH monthly performance report
Monthly ZBH research: returns, drawdown, relative strength, seasonality, and key stats.
ZBH monthly report
—
Key takeaways
- Zimmer Biomet (ZBH) closed August 2026 at $98.16, up 4.50% for the month and +6.64% over the trailing 12 months.
- Year-to-date, ZBH is +9.16%, underperforming the S&P 500 which has returned +12.89% YTD.
- The stock is trading +7.60% versus its 200-day moving average ($91.23), a bullish technical signal.
- Over the past three years, ZBH has underperformed the S&P 500 by −94.58%, with a relative strength index reading of 45.7.
- Win rate over the trailing 39 months stands at 43.6% — 17 positive months versus 22 negative months.
Zimmer Biomet ended August 2026 at $98.16, posting a monthly return of +4.50%. The S&P 500 returned +3.05% over the same window, leaving relative performance at +1.46%.
The current quarter stands at +11.37% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +7.60% versus the 200-day moving average ($91.23).
Year-to-date, ZBH is +9.16% against SPY +12.89%, a gap of −3.72%. The stock is currently −9.35% below its 52-week high, with maximum 3-year drawdown at −39.99%.
| Period | ZBH | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +2.45% | −0.20% | +2.65% |
| 1 Week | +2.52% | +3.90% | −1.39% |
| 1 Month | +4.50% | +3.05% | +1.46% |
| 3 Months | +19.08% | +7.11% | +11.97% |
| 6 Months |